Position
Creative Planning in Krystal Biotech, Inc.
Back to the book · All holders of KRYS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $163.5K$246.54 → $258.32
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 13.9K | $3.42M | — | — | — | 0.0% |
| Q1 2026 | 15.9K | $4.12M | $258.32 | $163.5K | $531.1K | 0.0% |